NOX2-dependent immunosuppression in chronic myelomonocytic leukemia

Johan Aurelius1,2, Alexander Hallner2, Olle Werlenius1,2

  • 1Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Summary

Chronic myelomonocytic leukemia (CMML) cells evade immune attack by releasing reactive oxygen species (ROS). This immunosuppressive mechanism causes lymphocyte death, offering a potential therapeutic target for CMML treatment.